185 related articles for article (PubMed ID: 15598787)
1. Polymorphism in the thymidylate synthase promoter enhancer region and risk of colorectal adenomas.
Chen J; Kyte C; Chan W; Wetmur JG; Fuchs CS; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2247-50. PubMed ID: 15598787
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer.
Chen J; Hunter DJ; Stampfer MJ; Kyte C; Chan W; Wetmur JG; Mosig R; Selhub J; Ma J
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):958-62. PubMed ID: 14578129
[TBL] [Abstract][Full Text] [Related]
3. Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers.
Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E
Eur J Cancer; 2005 Sep; 41(14):2176-83. PubMed ID: 16182121
[TBL] [Abstract][Full Text] [Related]
4. Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas.
Giovannucci E; Chen J; Smith-Warner SA; Rimm EB; Fuchs CS; Palomeque C; Willett WC; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):970-9. PubMed ID: 14578131
[TBL] [Abstract][Full Text] [Related]
5. A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil.
Iacopetta B; Grieu F; Joseph D; Elsaleh H
Br J Cancer; 2001 Sep; 85(6):827-30. PubMed ID: 11556832
[TBL] [Abstract][Full Text] [Related]
6. One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan.
Matsuo K; Ito H; Wakai K; Hirose K; Saito T; Suzuki T; Kato T; Hirai T; Kanemitsu Y; Hamajima H; Tajima K
Carcinogenesis; 2005 Dec; 26(12):2164-71. PubMed ID: 16051637
[TBL] [Abstract][Full Text] [Related]
7. Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas.
Ulrich CM; Bigler J; Bostick R; Fosdick L; Potter JD
Cancer Res; 2002 Jun; 62(12):3361-4. PubMed ID: 12067974
[TBL] [Abstract][Full Text] [Related]
8. Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction?
Ulrich CM; Kampman E; Bigler J; Schwartz SM; Chen C; Bostick R; Fosdick L; Beresford SA; Yasui Y; Potter JD
Cancer Epidemiol Biomarkers Prev; 1999 Aug; 8(8):659-68. PubMed ID: 10744125
[TBL] [Abstract][Full Text] [Related]
9. Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer.
Ishida Y; Kawakami K; Tanaka Y; Kanehira E; Omura K; Watanabe G
Anticancer Res; 2002; 22(5):2805-9. PubMed ID: 12530000
[TBL] [Abstract][Full Text] [Related]
10. Thymidylate synthase gene promoter polymorphisms are associated with TSmRNA expressions but not with microsatellite instability in colorectal cancer.
Calascibetta A; Cabibi D; Martorana A; Sanguedolce G; Rausa L; Feo S; Dardanoni G; Sanguedolce R
Anticancer Res; 2004; 24(6):3875-80. PubMed ID: 15736425
[TBL] [Abstract][Full Text] [Related]
11. [Thymidylate synthase gene promoter polymorphism in patients with advanced head and neck cancer treated by radio- and 5-fluorouracil chemotherapy].
Kiss-László Z; Nagy B; Thurzó L; Szabó J
Magy Onkol; 2006; 50(1):33-7. PubMed ID: 16617381
[TBL] [Abstract][Full Text] [Related]
12. Folate metabolism polymorphisms influence risk of colorectal adenoma recurrence.
Hubner RA; Muir KR; Liu JF; Sellick GS; Logan RF; Grainge M; Armitage N; Chau I; Houlston RS
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1607-13. PubMed ID: 16985020
[TBL] [Abstract][Full Text] [Related]
13. The methylenetetrahydrofolate reductase 677C-->T polymorphism and distal colorectal adenoma risk.
Levine AJ; Siegmund KD; Ervin CM; Diep A; Lee ER; Frankl HD; Haile RW
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):657-63. PubMed ID: 10919734
[TBL] [Abstract][Full Text] [Related]
14. Methionine synthase A2756G polymorphism interacts with alcohol and folate intake to influence the risk of colorectal adenoma.
Yamaji T; Iwasaki M; Sasazuki S; Sakamoto H; Yoshida T; Tsugane S
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):267-74. PubMed ID: 19124508
[TBL] [Abstract][Full Text] [Related]
15. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.
Lecomte T; Ferraz JM; Zinzindohoué F; Loriot MA; Tregouet DA; Landi B; Berger A; Cugnenc PH; Jian R; Beaune P; Laurent-Puig P
Clin Cancer Res; 2004 Sep; 10(17):5880-8. PubMed ID: 15355920
[TBL] [Abstract][Full Text] [Related]
16. Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study.
Tranah GJ; Giovannucci E; Ma J; Fuchs C; Hankinson SE; Hunter DJ
Carcinogenesis; 2004 Jul; 25(7):1211-8. PubMed ID: 14988221
[TBL] [Abstract][Full Text] [Related]
17. Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer.
Merkelbach-Bruse S; Hans V; Mathiak M; Sanguedolce R; Alessandro R; Rüschoff J; Büttner R; Houshdaran F; Gullotti L
Oncol Rep; 2004 Apr; 11(4):839-43. PubMed ID: 15010882
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of thymidylate synthase gene 5'- and 3'-untranslated region and risk of gastric cancer in Koreans.
Yim DJ; Kim OJ; An HJ; Kang H; Ahn DH; Hwang SG; Oh D; Kim NK
Anticancer Res; 2010 Jun; 30(6):2325-30. PubMed ID: 20651387
[TBL] [Abstract][Full Text] [Related]
19. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer.
Chen J; Giovannucci E; Kelsey K; Rimm EB; Stampfer MJ; Colditz GA; Spiegelman D; Willett WC; Hunter DJ
Cancer Res; 1996 Nov; 56(21):4862-4. PubMed ID: 8895734
[TBL] [Abstract][Full Text] [Related]
20. Dietary intake of folate and riboflavin, MTHFR C677T genotype, and colorectal adenoma risk: a Dutch case-control study.
van den Donk M; Buijsse B; van den Berg SW; Ocké MC; Harryvan JL; Nagengast FM; Kok FJ; Kampman E
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1562-6. PubMed ID: 15941973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
